Rask Invest Research Team

The Rask Invest research team produces daily ASX news and research on ASX-listed companies and funds. Join the conversation inside the free investor community. Click here to have your say.

99% of long-term investing is doing nothing; the other 1% changes your life

Rask Invest Research Team's latest insights

Today's ASX news

2 ASX shares I can’t ignore: SOL and BHP

The Washington H Soul Pattinson & Company Ltd (ASX:SOL) share price is up 6.4% since the start of 2024. It’s probably worth asking, ‘is the SOL share price good value?’

Today's ASX news

RMD and ASX Ltd: 2 ASX shares to dig into

The Resmed CDI (ASX:RMD) share price has jumped 39.9% since the start of 2024. It’s probably worth asking, ‘is the RMD share price cheap?’

Today's ASX news

A deep dive into PME shares

The Pro Medicus Limited (ASX:PME) share price is up 85.1% since the start of 2024. It’s probably worth asking, ‘is the PME share price undervalued?’

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.